Dermira Prices IPO At $16.00 Per Share - Quick Facts

(RTTNews) - Dermira Inc. (DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients, announced the pricing of its initial public offering of 7.81 million shares of common stock at a price to the public of $16.00 per share.

Recently, the company disclosed in a regulatory filing that it expected the initial public offering price to be between $14.00 and $16.00 per share of common stock.

The shares are expected to begin trading on The NASDAQ Global Select Market on October 3, 2014 under the symbol DERM.

In addition, Dermira has granted the underwriters a 30-day option to purchase up to an additional 1.17 million shares of common stock to cover over-allotments, if any. Concurrently with the offering, Dermira is also selling through a private placement 468,750 shares of its common stock to UCB S.A., an existing stockholder, at the initial public offering price.

Citigroup and Leerink Partners are acting as joint book-running managers for the offering. Guggenheim Securities and Needham & Company are acting as co-managers.